Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-15

Clinical Trial Update: Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dydrogesterone with micronized progesterone for threatened miscarriage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dydrogesterone (dydrogesterone)
  • Micronized Progesterone (Progesterone, micronized)

Snippet

Sponsor: Konya Meram State Hospital | Conditions: Miscarriage Threatening | Phase 4 | Status: UNKNOWN